Apyx Medical Corporation
APYX
$3.63
-$0.06-1.63%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 52.84M | 47.90M | 46.51M | 47.29M | 48.10M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 52.84M | 47.90M | 46.51M | 47.29M | 48.10M |
| Cost of Revenue | 19.80M | 17.89M | 17.85M | 18.21M | 18.74M |
| Gross Profit | 33.04M | 30.01M | 28.67M | 29.08M | 29.36M |
| SG&A Expenses | 36.12M | 35.97M | 37.09M | 39.87M | 43.13M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 59.29M | 57.41M | 58.82M | 62.57M | 66.95M |
| Operating Income | -6.45M | -9.51M | -12.31M | -15.28M | -18.85M |
| Income Before Tax | -10.84M | -14.26M | -17.05M | -19.89M | -23.31M |
| Income Tax Expenses | 270.00K | 265.00K | 247.00K | 248.00K | 252.00K |
| Earnings from Continuing Operations | -11.11 | -14.52 | -17.29 | -20.14 | -23.56 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -106.00K | -16.00K | 34.00K | 104.00K | 96.00K |
| Net Income | -11.21M | -14.54M | -17.26M | -20.04M | -23.46M |
| EBIT | -6.45M | -9.51M | -12.31M | -15.28M | -18.85M |
| EBITDA | -5.79M | -8.93M | -11.75M | -14.70M | -18.25M |
| EPS Basic | -0.27 | -0.36 | -0.45 | -0.55 | -0.66 |
| Normalized Basic EPS | -0.17 | -0.22 | -0.28 | -0.34 | -0.41 |
| EPS Diluted | -0.27 | -0.36 | -0.45 | -0.55 | -0.66 |
| Normalized Diluted EPS | -0.17 | -0.22 | -0.28 | -0.34 | -0.41 |
| Average Basic Shares Outstanding | 164.37M | 160.42M | 154.32M | 148.23M | 142.15M |
| Average Diluted Shares Outstanding | 164.37M | 160.42M | 154.32M | 148.23M | 142.15M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |